Novel drugs from marine microorganisms

Critical Reviews in Microbiology

Volumn 37, Issue 3, 2011, Pages 245-249

  Javed, Faraza ^a   Qadir, M Imran ^a   Janbaz, Khalid Hussain ^b   Ali, Muhammad ^b  

^a GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Aquatic foodstuff; Bioactives; Biofilms; Marine microorganisms

Indexed keywords

4,5,6 TRIHYDROXY METHYPHTHALIDE; AGAR; AGROCHELIN; ALGINIC ACID; ANTIBIOTIC AGENT; BRYOSTATIN; CARRAGEENAN; CHITIN DERIVATIVE; CHITOSAN; CONOTOXIN; CONTIGNASTEROL; DAUNORUBICIN; DEHYDRODIDEMNIN B; DOLASTATIN; ERIBULIN; GLUCOSAMINE; HALICHONDRIN B; LOLOATIN B; MANZAMINE A; NIGERICIN; OMEGA 3 FATTY ACID; PLINABULIN; PYRONE DERIVATIVE; SALINOSPORAMIDE A; SESBANIMIDE DERIVATIVE; TASIDOTIN; THIOMARINOL; TRABECTEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHENE DERIVATIVE;

ALGA; ASTHMA; BIOFILM; CYANOBACTERIUM; DINOFLAGELLATE; DRUG ISOLATION; DRUG MANUFACTURE; FUNCTIONAL FOOD; FUNGUS; KARLODINIUM VENEFICUM; MARINE ALGAE; MARINE BACTERIUM; MARINE CYANOBACTERIA; MARINE ENVIRONMENT; MARINE FUNGUS; MARINE NEMATODE; MARINE SPECIES; NEMATODE; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; EUKARYOTA; HUMANS; SEAWATER;

DINOPHYCEAE; KARLODINIUM;

EID: 79959759002     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2011.576234     Document Type: Review

References (46)

1. Ablan S., Rawat S., Viard M, Wang J, Puri A, Blumenthal R. (2006). The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Virol J, 3, 104.
2. Adolf JE, Bachvarof TR, Place AR. (2009). Environmental modulation of karlotoxin levels in strains of the cosmopolitan dinofagellate, Karlodinium venefcum (Dinophyceae). J Phycol, 45, 176-192.
3. Agargun M, Dulger H, Inci R, Kara H, Ozer O, Sekeroglu M, Besiroglu L. (2004). Serum lipid concentrations in obsessive-compulsive disorder patients with and without panic attacks. Can J Psychiatry, 49, 776-778. (Pubitemid 40094951)
4. Alchorn A. (2007). Lipid rafts observed in cell membranes. Sci Tech Rev, 9.
5. Bachvarof TR, Adolf JE, Squier AH, Harvey HR, Place AR. (2008). Characterization and quantifcation of karlotoxins by liquid chromatography-mass spectrometry. Harmful Algae, 7, 473-484.
6. Baldwin JE. (1992). Biosynthesis of manzamines, Tetrahedron Lett, 33, 2059-2062.
7. Berg J, Tymoczko J, Stryer L. (2002). The Biosynthesis of Membrane Lipids and Steroids. Biochemistry by W.H. Freeman and Company. Chapter 26. 6th Edition.
8. Cabrita MT, Vale C, Rauter AP. (2010). Halogenated compounds from marine algae. J Nat, 8(8), 2301-2317.
9. Cuevas C, Francesch A. (2009). Development of Yondelis (trabectedin, ET-743): a semisynthetic process solves the supply problem. Nat Prod Rep, 26, 322-337.
10. Cuevas C, Perez M, Martin MJ, Chicharro JL, Fernandez-Rivas C, Flores M, Francesch A, Gallego P, Zarzuelo M, de la Calle F. (2002). Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett, 2, 2545-2548.
11. Demydchuk Y, Sun Y, Hong H, Staunton J, Spencer JB, Leadlay PF. (2008). Analysis of the tetronomycin gene cluster: insights into the biosynthesis of a polyether tetronate antibiotic. Chembiochem, 9, 1136-1145.
12. Fantini F, Barrantes F. (2009). Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta, 1788. 2345-2361.
13. Fantini J, Garmy N, Mahfoud R, Yahi N. (2002). Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases. Expert Rev Mol Med, 4(27), 1-22.
14. Guo YQ, Warwick RM, Zhang ZN, Mu FH. (2002). Free living marine nematodes as pollution indicator. J Environ Sci, 14(4), 558-62. (Pubitemid 36006450)
15. Harvey BM, Mironenko T, Sun Y, Hong H, Deng Z, Leadlay PF, Weissman KJ, Haydock SF. (2007). Insights into polyether biosynthesis from analysis of the nigericin biosynthetic gene cluster in Streptomyces sp. DSM4137. Chem Biol, 14, 703-714. (Pubitemid 46920987)
16. Hentschel U, Usher KM, Tavior MVV. (2007). Marine sponges as microbial fermentor. J Nat Prod, 16, 275-279.
17. Hill RT, Hamann MT, Peraud O, Kasanah N. (2004). Manzamine Producing Actinomycetes. National center for natural product research, USA. WO 2004/013297A3.
18. Hoshi M, Endo T. (2000). Microbial and chemical conversion of antibiotic K41. II. Preparation of K41-DA1-DA2 and -DA3 deamicetosyl derivatives of antibiotic K41. J Antibiot (Tokyo). 53, 1154-1157.
19. Jayakumar R, Chennazhi KP, Anitha A, Ehrlich H, Tamura H, Nair SV. (2010). Chitin of Marine Origin: Membranes, Scafolds and Teir Biomedical Applications, Special issue marine functional food. MDPI, 55(7), 675-709.
20. Kijjojoa A, Sawangwong P. (2004). Drugs and cosmetics from the sea. J MDPI, 2, 73-82.
21. Kobayashi M, Natsume T, Tamaoki S, Watanabe J, Asano H, Mikami T, Miyasaka K, Miyazaki K, Gondo M, Sakakibara K. (1997). Antitumor activity of TZT-1027, a novel dolastatin 10 derivative. Jpn J Cancer, 88, 316-327. (Pubitemid 27170493)
22. Luo C, Wang K, Liu D, Li Y, Zhao O. (2008). The functional roles of lipid rafts in T cell activation, immune diseases and HIV infection and prevention. Cell Mol Immunol, 5, 1-7.
23. Mikami Y, Takahashi K, Yazawa K, Arai T, Namikoshi M, Iwasaki S, Okuda S. (1985). Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae. J Biol Chem, 260, 344-348. (Pubitemid 15164057)
24. Newman DJ, Cragg GM, Snader KM. (2000). The infuence of natural products upon drug discovery. Nat Prod Rep, 17, 215-234. (Pubitemid 30390787)
25. Newman DJ, Cragg GM, Snader KM. (2003). Natural products as a source of new drugs over the period 1981-2002. J Nat Prod, 66, 1022-1037. (Pubitemid 36909859)
26. Newman SE, Eribulin. (2007). A simplifed ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer. Curr Opin Investig Drugs, 8, 1057-1066.
27. Ocio EM, Maiso P, Chen X, Garayoa M, Alvarez-Fernandez S, San-Segundo L, Vilanova D, Lopez-Corral L, Montero JC, Hernandez-Iglesias T. (2009). Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks. Nature Prod, 113, 3781-3791.
28. Oftedal L, Selheim F, Wahlsten M, Sivonen K, Døskeland SO, Herfndal L. (2010). Marine cynobacteria contain apoptosis inducing activity synergizing with daunorubicin to kill leukemia cells but not cardiomyocytes. J Nat Prod, 8(10), 2659-2672.
29. Pandey SC, Sassetti C. (2008). Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci, 105, 4376-4380. (Pubitemid 351754388)
30. Peng J, Hill R, Place A, Anklin C, Hamann MT. (2007). Marine microbes: the critical role they play in sustainable production of starting materials for the synthesis of drug leads and the structure for the elusive Pfesteria-associated fsh killing toxin using 13C enrichment and dual cryoprobe NMR studies. Papers, United States. 25-29.
31. Peng J, Kudrimoti S, Prasanna S, Odde S, Doerksen RJ, Pennaka HK, Choo Y, Rao KV, Tekwani BL, Madgula V. (2010). Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinfammation and cerebral infections. J Med Chem, 53, 61-76.
32. Peng J, Place AR, Yoshida W, Clemens A, Hamann MT. (2010). Structure and absolute confguration of karlotoxin-2, an ichthyotoxin from the marine dinofagellate Karlodinium venefcum. J Am Chem Soc, 132, 3277-3279.
33. Penseyan A, Kielleberg Egan S. (2010). Development of novel drugs from marine microorganisms. Nature, 8(3), 438-59.
34. Place AR, Bai X, Kim S, Sengco MR, Coats DW. (2009). Dinofagellate host-parasite sterol profles dictate karlotoxin sensitivity. J Phycol, 45, 375-385.
35. Place AR, Deeds JR. (2004). Dinofagellate Karlotoxins, Methods of Isolation and Uses Tereof. WO 2004/100659 A2. 21, 780-726.
36. Qadir MI, Malik SA. (2011). Genetic Variation in the HR Region of the env Gene of HIV: A Perspective for Resistance to HIV Fusion Inhibitors. AIDS Res Hum Retrovir, 27(1): 57-63.
37. Qadir MI, Malik SA. (2010). HIV Fusion Inhibitors. Rev Med Virol, 20:23-33. DOI: 10.1002/rmv.631
38. Rinehart (2000). Antitumor compounds from tunicates. Med Res Rev, 20, 1-27.
39. Rinehart KL, Bible V, Sakai KC, Sullins R, Li DW, Didemnins KM, Tunichlorin. (1998). Novel natural products from the marine Tunicates. J Nat Prod, 51, 1-21.
40. Scheuer PJ. (1996). Marine metabolites as Drug Leads Retrospect and prospects: Colorado. J Nat, 1-12.
41. Sheng J, Malkiel E, Katz J, Adolf JE, Place AR. (2010). A dinofagellate exploits toxins to immobilize prey prior to ingestion. Proc Natl Acad Sci, 107, 2082-2087.
42. Simons K, Ehehalt R. (2002). Cholesterol, lipid rafts and disease. J Clin Invest, 110, 597-603.
43. Van Wagoner RM, Deeds JR, Satake M, Ribeiro AA, Place AR, Wright JLC. (2008). Isolation and characterization of karlotoxin 1, a new amphipathic toxin from Karlodimiun venefcum. Tetrahedron Lett, 49, 6457-6461.
44. Wang D. (2008). Neurotoxins from marine dinofagellates: a brief review. Mar Drugs, 6, 349-371. (Pubitemid 351919086)
45. Yamada K, Okijia M, Kigoshi H, Suenaga, Kigoshi HS. (2000). Cytotoxic substances from Opisthobranch molluscs, in drugs from the sea. Basel, 59-73.
46. Zewail-Foote M, Hurley L, Ecteinascidin H. (1999). A minor groove alkylator that binds DNA towards the major groove. J Med Chem, 42, 2493-2497. (Pubitemid 29344290)